Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| SPHL | Springview | $7.13 | -$10.29 | -59.08% | 3.3M | $203M | $1.92$62.40 |
| ANPA | Hong Kong Prosperous Sheep | $96.01 | -$61.88 | -39.19% | 96.3K | $2.0B | $2.80$180.64 |
| MLEC | Moolec Science | $5.24 | -$2.46 | -31.95% | 472.3K | $5.6M | $3.08$157.05 |
| RAYA | Erayak Power Solution Group | $2.84 | -$1.09 | -27.73% | 424.2K | $3.5M | $2.75$737.00 |
| PAVM | PAVmed | $6.71 | -$2.04 | -23.31% | 75.2K | $9.3M | $6.00$26.85 |
| SMCZ | Tidal Trust II - Defiance Daily Target 2x Short Smci ETF | $45.00 | -$10.17 | -18.43% | 436.1K | - | $19.85$225.57 |
| MTEX | Mannatech | $7.58 | -$1.55 | -17.00% | 52.4K | $17M | $6.90$16.49 |
| IONZ | Tidal Trust II - Defiance Daily Target 2x Short Ionq ETF | $15.85 | -$3.09 | -16.30% | 2.8M | - | $12.48$137.71 |
| SGML | Sigma Lithium | $11.96 | -$2.30 | -16.11% | 10M | $1.6B | $4.25$16.87 |
| BNKK | Bonk | $3.38 | -$0.58 | -14.65% | 1.3M | $21M | $2.33$46.90 |
Related Articles
Featured Article
What's the Outlook for Arbutus Biopharma?
Keith Speights and Brian Orelli, PhD|Feb 5, 2022
The company could have great prospects if its hepatitis B virus therapy is successful in clinical testing.
3 Healthcare Stocks That Rocketed Higher in July
Cory Renauer|Aug 3, 2020
Here's what drove shares of these healthcare stocks through the roof last month.
Tiny Arbutus Biopharma Wins Patent Litigation Fight with COVID-19 Vaccine Implications
Taylor Carmichael|Jul 24, 2020
The ruling means Moderna may have to pay royalties on its mRNA-based vaccines -- including its coronavirus candidate.
Advertisement
Is Sasol the 1 Petrochemical Stock to Own?
Alison Healey|Jan 23, 2020
The South Africa-based energy company has a big new project that could provide a nice boost to earnings, but it's also created headaches.
Why Urban Outfitters, Sasol, and Pure Storage Slumped Today
Dan Caplinger|May 22, 2019
Disappointing results and other bad news held these stocks back.
Why American Outdoor Brands, Sasol, and Iovance Biotherapeutics Slumped Today
Dan Caplinger|Sep 20, 2017
These stocks held down the stock market. Find out why.
Currency Fluctuations Hit Sasol, but the Company Has Its Growth Plans in Place
Neha Chamaria|Aug 23, 2017
The South African energy and chemicals company continues to grow its profits despite the headwinds.
Sasol Sees Mixed Sales to Start 2017
Dan Caplinger|May 6, 2017
The South African energy company's production and sales metrics were largely mixed.
Sasol Looks to North America for Growth
Dan Caplinger|Mar 13, 2017
The company expects to keep costs under control to deal with continued challenging conditions in the energy industry.
Sasol's Energy Production Remains Under Pressure
Dan Caplinger|Nov 14, 2016
Energy's recovery hasn't led to huge gains in sales volumes throughout most of the company.
